Prediction of thiopurine failure in pediatric Crohn's disease

Autor: Tereza Lerchova, Ondrej Hradsky, Michal Kulich, Gabor Veres, Jorge Amil Dias, Małgorzata Sładek, Sanja Kolacek, Stephanie Van Biervliet, Jan Melek, Daniela E. Serban, Katrine Winther, Tim de Meij, Jan Schwarz, Kaija-Leena Kolho, Johanna C. Escher, Jiri Bronsky

Publikováno v: Lerchova, T, Hradsky, O, Kulich, M, Veres, G, Dias, J A, Sładek, M, Kolacek, S, van Biervliet, S, Melek, J, Serban, D E, Winther, K, de Meij, T, Schwarz, J, Kolho, K-L, Escher, J C & Bronsky, J 2022, ' Prediction of thiopurine failure in pediatric Crohn’s disease : pediatric IBD Porto group of ESPGHAN ', Pediatric Research . https://doi.org/10.1038/s41390-022-02270-x
Pediatric Research, 93(6), 1659-1666. Lippincott Williams & Wilkins
Pediatric Research. Lippincott Williams and Wilkins

Background Maintaining of remission early in the disease course of Crohn's disease (CD) is essential and has major impact on the future prognosis. This study aimed to identify baseline predictors to develop model allowing stratification of patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f1b80761801f5942637cdf2afbceacb
https://doi.org/10.1038/s41390-022-02270-x

Is mean platelet volume a good predictor of sustained response to one year infliximab therapy in pediatric patients with Crohn's disease?

Autor: Roma, Herman, Małgorzata, Sładek, Stanisław, Pieczarkowski, Paulina, Dumnicka, Krzysztof, Fyderek

Publikováno v: Folia medica Cracoviensia. 57(2)

Over the past years, there is a growing number of newly diagnosed pediatric patients with Crohn's disease (CD). Severe course of CD often requires biological treatment with Infliximab (IFX). Loss of response to biological treatment is a major problem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d92e7349e3b45d183a4c43b9507160a9
https://pubmed.ncbi.nlm.nih.gov/29121038

[Biological treatment of inflammatory bowel diseases in children in the years 2004-2013 in Poland]

Autor: Barbara, Iwańczak, Józef, Ryzko, Jarosław, Kierkuś, Piotr, Jankowski, Małgorzata, Sładek, Agata, Wasilewska, Piotr, Landowski, Mariusz, Szczepanik, Elzbieta, Krzesiek, Edyta, Sienkiewicz, Anna, Szaflarska-Popławska, Sabina, Wiecek, Jarosław, Kwiecien, Magdalena, Kacperska, Bartosz, Korczowski, Jolanta, Maślana

Publikováno v: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 36(215)

In the last years an increase in Crohn's disease morbidity in children is observed together with constant morbidity of ulcerative colitis. The course of these diseases is severe, younger children are affected and the diseases are resistant to convent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c381132ed8125c636a3ef05755f804f6
https://pubmed.ncbi.nlm.nih.gov/24964507

[The low prevalence of Helicobacter pylori gastritis in newly diagnosed inflammatory bowel disease children and adolescent]

Autor: Małgorzata, Sładek, Urszula, Jedynak-Wasowicz, Andrzej, Wedrychowicz, Kinga, Kowalska-Duplaga, Stanisław, Pieczarkowski, Krzysztof, Fyderek

Publikováno v: Przeglad lekarski. 64

Data concerning prevalence rate of Helicobacter pylori gastritis in inflammatory bowel disease (IBD) patients is conflicting. We had studied the prevalence of Hp gastritis in newly diagnosed inflammatory bowel disease children before any pharmacologi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::47427289b4c8cbe4150e52ccd997507e
https://pubmed.ncbi.nlm.nih.gov/18431918

Infliximab Therapy Could Decrease the Risk of the Development of Thyroid Disorders in Pediatric Patients With Crohn's Disease

Autor: Aleksandra Furtak, Anna Maria Wedrychowicz, Malgorzata Sladek, Andrzej Wedrychowicz, Krzysztof Fyderek, Jerzy Starzyk

Publikováno v: Frontiers in Endocrinology, Vol 11 (2020)

Autoimmune diseases, including autoimmune thyroid diseases (AITDs), may be associated with Crohn's disease (CD). Taking into consideration the role of tumor necrosis factor alpha (TNF-alpha) in the immune-mediated inflammation that underlies both dis

Externí odkaz: https://doaj.org/article/91eca2627f4e4307bd4123a0df22326d